Author:
Qin Lijun,Qiu Hongbing,Zhang Minjie,Zhang Fenghua,Yang Hongfang,Yang Liu,Jia Li,Qin Kaiyun,Jia Ling,Dou Xiaomeng,Cheng Lili,Sang Meixiang,Zhang Chao,Shan Baoen,Zhang Zhengmao
Funder
International Cooperation Research Program of Science and Technology Agency in Hebei Province
Subject
Pharmacology,General Medicine
Reference24 articles.
1. Cancer of the ovary;Cannistra;N. Engl. J. Med.,2004
2. Ovarian cancer: progress and continuing controversies in management;Moss;Eur. J. Cancer,2002
3. Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: biological data and clinical implications;Gadducci;Eur. J. Gynaecol. Oncol.,2002
4. CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells;Nesbeth;J. Immunol,2010
5. Prospects for CD40-directed experimental therapy of human cancer;Tong;Cancer Gene Ther.,2003
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献